Brepoels Lieselot, Stroobants Sigrid, De Wever Walter, Spaepen Karoline, Vandenberghe Peter, Thomas Jose, Uyttebroeck Anne, Mortelmans Luc, De Wolf-Peeters Christiane, Verhoef Gregor
Departments of Nuclear Medicine, University Hospital Gasthuisberg and Catholic University Leuven, Leuven, Belgium.
Leuk Lymphoma. 2007 Aug;48(8):1539-47. doi: 10.1080/10428190701422414.
Until recently, response assessment in patients with Hodgkin's lymphoma (HL) was primarily performed by computed tomography (CT). Based on CT, International Workshop Criteria (IWC) were developed and widely used. Fluorodeoxyglucose positron emission tomography (FDG-PET) has a higher sensitivity and specificity compared with that of CT, and Revised International Workshop Criteria (IWC + PET) were recently proposed, which combine both imaging techniques. We determined whether these integrated IWC + PET-criteria can more accurately predict outcome compared with IWC-criteria in 56 patients with HL. Of the original 56 patients, nine patients relapsed and 47 are still in remission after a median follow-up of 9 years. Based on IWC-criteria, 15 patients had a complete remission (CR) after chemotherapy, 20 had complete remission unconfirmed (CRu), 19 had partial remission (PR) and two had stable disease (SD). In comparison, by IWC + PET, 47 had CR, seven had PR and two had SD. For IWC, outcome was not significantly different in patients with CR/CRu compared to PR (P = 0.61), while for IWC + PET criteria, time-to-next-treatment was significantly shorter in patients with PR compared to CR (P = 0.01). Therefore, IWC + PET-guidelines provide a more accurate response classification compared with that of IWC-guidelines, and are the preferred method for response assessment in patients with Hodgkin's lymphoma.
直到最近,霍奇金淋巴瘤(HL)患者的疗效评估主要通过计算机断层扫描(CT)进行。基于CT制定了国际研讨会标准(IWC)并被广泛应用。与CT相比,氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)具有更高的敏感性和特异性,最近提出了修订后的国际研讨会标准(IWC + PET),该标准结合了两种成像技术。我们确定了在56例HL患者中,与IWC标准相比,这些综合的IWC + PET标准是否能更准确地预测预后。在最初的56例患者中,9例复发,47例在中位随访9年后仍处于缓解状态。根据IWC标准,化疗后15例患者达到完全缓解(CR),20例为未确认的完全缓解(CRu),19例为部分缓解(PR),2例为疾病稳定(SD)。相比之下,根据IWC + PET标准,47例为CR,7例为PR,2例为SD。对于IWC,CR/CRu患者与PR患者的预后无显著差异(P = 0.61),而对于IWC + PET标准,PR患者与CR患者相比,下次治疗时间明显缩短(P = 0.01)。因此,与IWC标准相比,IWC + PET指南提供了更准确的疗效分类,是霍奇金淋巴瘤患者疗效评估的首选方法。